Quarterly report pursuant to Section 13 or 15(d)

Business Combinations - Summary of Fair Value of Merger Consideration (Details)

v3.22.2.2
Business Combinations - Summary of Fair Value of Merger Consideration (Details) - Pandologic Ltd [Member]
$ in Thousands
Sep. 14, 2021
USD ($)
Business Acquisition [Line Items]  
Cash consideration at closing $ 58,733
Equity consideration at closing 31,500
Contingent earnout 39,512
Net working capital adjustment 5,818
Total $ 135,563